Table 1.
Clinical and demographic features of individual subjects (incident cases).
| Subject | Race/gender | Presentation | Age at | estGFR | Urinary protein/ | BMI | SBP/DBP | Serum Gd-IgA1 |
|---|---|---|---|---|---|---|---|---|
| biopsy | (mL/min/1.73 m2) | creatinine ratio | percentile | percentile | level (units/mL) | |||
| A1 | C/M | Microhematuria, | 17.6 | 59 | 1.17 | 98 | 95–99/<50 | 262 |
| proteinuria | ||||||||
| M2 | C/M | Isolated proteinuria | 13.8 | 78 | 1.24 | 26 | 95–99/50–90 | 889 |
| M15 | C/F | Gross hematuria | 11.2 | 80 | 1.31 | <1 | <50/50–90 | 1076 |
| M16 | C/F | Gross hematuria | 8.7 | 75 | 1.00 | 57 | 50–90/<50 | 1073 |
| M17 | C/M | Gross hematuria | 13.4 | 108 | 3.10 | 11 | 50–90/50–90 | 1534 |
| M18 | C/F | Recurrent gross hematuria | 12.5 | 107 | 2.96 | 17 | >99/<50 | 1155 |
| M19 | AA/F | Gross hematuria, | 15.9 | 49 | 2.97 | 52 | <50, <50 | 3401 |
| rapidly progressive | ||||||||
| glomerulonephritis | ||||||||
| M21 | AA/M | Isolated proteinuria | 5.1 | 94 | 3.58 | 96 | <50, 50–90 | 747 |
| M22 | C/M | Gross hematuria, | 8.6 | 75 | 1.33 | 49 | 95–99/50–90 | 803 |
| acute kidney injury | ||||||||
| M26 | AA/M | Gross hematuria | 8.8 | 120 | 3.70 | 30 | 90–95/50–90 | 470 |
| M28 | C/F | Gross hematuria, | 16.7 | 63 | 1.36 | 40 | 90–95/50–90 | 1110 |
| proteinuria | ||||||||
| M29 | C/M | Gross hematuria | 12.8 | 96 | 0.95 | 41 | >99/95–99 | 659 |
| M30 | C/M | Gross hematuria, | 15.0 | 61 | 2.89 | 63 | 90–95/50–90 | 364 |
| acute kidney injury | ||||||||
| M31 | C/M | Gross hematuria | 16.2 | 84 | 0.25 | 89 | 50–90/50–90 | 2513 |
| T2 | C/M | Microhematuria, proteinuria, | 17.8 | 40 | 1.27 | 44 | 95–99/50–90 | 796 |
| Chronic kidney | ||||||||
| disease stage 3 |
AA: African-American; BMI: body mass index; C: Caucasian; estGFR, estimated glomerular filtration rate; DBP: diastolic blood pressure; SBP: systolic blood pressure; microhematuria, >5 RBC/high powered field.